galantamine has been researched along with physostigmine in 66 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (24.24) | 18.7374 |
1990's | 11 (16.67) | 18.2507 |
2000's | 21 (31.82) | 29.6817 |
2010's | 13 (19.70) | 24.3611 |
2020's | 5 (7.58) | 2.80 |
Authors | Studies |
---|---|
Bigg, DC; Briley, M; Calmel, F; Carilla, E; Vidaluc, JL | 1 |
Bigg, D; Briley, M; Calmel, F; Carilla, E; Chopin, P; Stenger, A; Vidaluc, JL | 1 |
Brossi, A; Greig, NH; Holloway, HW; Whittaker, NF; Yu, QS; Zhu, X | 1 |
Alley, GM; Brossi, A; Deschamps, JR; Greig, NH; Holloway, HW; Kulkarni, SS; Lahiri, DK; Luo, W; Parrish, D; Yu, QS; Zhan, M | 1 |
Brossi, A; Greig, NH; Holloway, HW; Kulkarni, SS; Lahiri, DK; Luo, W; Parrish, DA; Shafferman, A; Tweedie, D; Yu, QS | 1 |
Decker, M; Lehmann, J; Rommelspacher, H; Schott, Y | 1 |
Arnold, N; Brandt, W; Geissler, T; Kehlen, A; Porzel, A; Schlenzig, D; Wessjohann, L | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Ansari, FL; Hall, CD; Jabeen, F; Katritzky, AR; Oliferenko, AA; Oliferenko, PV; Pillai, GG | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Awang, K; Khaw, KY; Liew, SY; Litaudon, M; Murugaiyah, V; Wan Othman, WNN | 1 |
Darekar, MN; Gurjar, AS; Ooi, L; Yeong, KY | 1 |
Ji, J; Peng, Y; Rakesh, KP; Wang, S; Xu, M; Zhu, L | 1 |
Al Mamun, A; Cahlíková, L; Hulcová, D; Kobrlová, T; Kohelová, E; Korábečný, J; Kučera, T; Kuneš, J; Maříková, J; Nováková, L; Peřinová, R; Ritomská, A | 1 |
Curtis, MA; Lin, SX; Sperry, J | 1 |
Cahlíková, L; Carmen Catapano, M; Hulcová, D; Janoušek, J; Jenčo, J; Kohelová, E; Korábečný, J; Kučera, T; Kuneš, J; Maafi, N; Maříková, J; Mecava, M; Nováková, L; Pidaný, F; Prchal, L; Schmidt, M; Shammari, LA; Špulák, M | 1 |
Andricopulo, AD; Cenci, AR; de Oliveira, AS; Ferreira, LLG; Machado, V; Nunes, RJ; Sandjo, LP; Sens, L; Teixeira, KF; Tizziani, T; Yunes, RA | 1 |
Aleksandriĭskaia, IE; Brestkina, LM; Sofronov, GA; Tonkopiĭ, VD | 1 |
Cozanitis, DA | 1 |
Barz, H; Bickel, U; Cervos-Navarro, J; Fischer, JP; Gusztony, G; Kaden, B; Kewitz, H; Thomsen, T | 1 |
Dubovitskaia, SI; Khromova, ON; Prozorovskiĭ, VB; Vladeeva, NV | 1 |
Schmidt, J; Wolf, H | 1 |
Andreas, K; Lehmann, K; Walther, H | 1 |
Kumbier, E; Liebmann, H; Matthies, H | 1 |
Gladysheva, NI; Khromova, ON; Prozorovskiĭ, VB | 1 |
Prozorovskiĭ, VB | 1 |
Gumulka, W; Kostowski, W | 1 |
Chanley, JD; Durant, RC; Friess, SL; Mezzetti, T | 1 |
Il'iuchenok, RIu; Nesterenko, LN | 1 |
Kagei, K; Koshiro, A; Shirai, H; Uyeo, S; Yashiro, T | 1 |
Cozanitis, DA; Friedmann, T; Fürst, S | 1 |
Ducardus, R; Dworacek, B; Dzoljic, MR; Rupreht, J; Schmitz, PI | 1 |
Krivoĭ, II; Kuleshov, VI; Matiushkin, DP; Sanotskiĭ, VI; Shabunova, IA | 1 |
Abdel Ghani, EM; Cooper, JC; Gutbrod, O; Hermsen, B; Lobron, C; Reinhardt, S; Schrattenholz, A; Soskiç, V; Storch, A; Weber, KH | 1 |
Bahro, M; Berger, M; Gann, H; Hohagen, F; Lis, S; Riemann, D; Stadmüller, G | 1 |
Feng, J; Liu, JS; Tang, XC; Xu, H; Zhou, TX | 1 |
Albuquerque, EX; Alkondon, M; Lindstrom, J; Maelicke, A; Peng, X; Pereira, EF; Reinhardt, S; Whiting, P | 1 |
Johansson, M; Nordberg, A | 1 |
Albuquerque, EX; Maelicke, A; Pereira, EF; Reinhardt-Maelicke, S; Schrattenholz, A | 1 |
Camacho, F; Smith, CP; Vargas, HM; Winslow, JT | 1 |
Mielke, R | 1 |
Robert, P | 1 |
Houghton, PJ; Howes, MJ; Perry, NS | 1 |
Harmon, HJ; Legako, JA; White, BJ | 1 |
Butler, R; Prabhakaran, P; Warner, J | 1 |
PODLESNAIA, AI | 1 |
Caricati-Neto, A; D'angelo, LC; Garcia, AG; Hyppolito Jurkiewicz, N; Jurkiewicz, A; Reuter, H | 1 |
Arya, P; Butler, R; Warner, J | 2 |
Bermudez, I; Groot-Kormelink, PJ; Smulders, CJ; van Kleef, RG; Vijverberg, HP; Zwart, R | 1 |
Bottlaender, M; Coulon, C; Dollé, F; Ottaviani, M; Syrota, A; Valette, H | 1 |
Bertchume, A; Colvin, J; Csernansky, JG; Dong, H; Martin, M; Shah, R | 1 |
Castro, A; Martinez, A | 1 |
Butler, R; Warner, J; Wuntakal, B | 1 |
Collins, D; Easwaramoorthy, B; Leslie, FM; Mukherjee, J; Pichika, R; Potkin, SG | 1 |
Kircher, T; Leucht, S; Thienel, R; Voss, B | 1 |
Bajda, M; Malawska, B; Musiał, A | 1 |
Ehret, A; Feuerstein, TJ; Förster, S; Jackisch, R; Kammerer, M; Rothmaier, AK; Zentner, J | 1 |
Ilavazhagan, G; Maiti, P; Muthuraju, S; Prasad, D; Sharma, AK; Singh, SB; Solanki, P | 2 |
Auber, A; Chiamulera, C; Giarola, A | 1 |
Ilavazhagan, G; Maiti, P; Muthuraju, S; Pati, S; Prasad, D; Sharma, AK; Singh, SB; Solanki, P | 1 |
Cohen, JB; Hamouda, AK; Kimm, T | 1 |
Cesario, A; Del Bufalo, A; Fini, M; Frustaci, A; Russo, P | 1 |
Barnhart, TE; Christian, BT; Farhoud, M; Higgins, AT; Hillmer, AT; Lao, PJ; Mukherjee, J; Wooten, DW | 1 |
Fitzgerald, PJ; Ghimire, A; Hale, PJ; Watson, BO | 1 |
14 review(s) available for galantamine and physostigmine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Triazole derivatives as inhibitors of Alzheimer's disease: Current developments and structure-activity relationships.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Neuroprotective Agents; Structure-Activity Relationship; Triazoles | 2019 |
Pyridine alkaloids with activity in the central nervous system.
Topics: Alkaloids; Amphibians; Animals; Bacteria; Central Nervous System Diseases; Fungi; Nicotine; Plants; Pyridines; Receptors, Nicotinic | 2020 |
Pharmacokinetic studies of cholinesterase inhibitors.
Topics: Adult; Aged; Alzheimer Disease; Female; Galantamine; Humans; Male; Middle Aged; Physostigmine; Tacrine | 1993 |
Understanding and managing behavioural symptoms in Alzheimer's disease and related dementias: focus on rivastigmine.
Topics: Acetylcholine; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Cognitive Behavioral Therapy; Disease Progression; Donepezil; Galantamine; Humans; Indans; Neuroprotective Agents; Phenylcarbamates; Physostigmine; Piperidines; Rivastigmine; Tacrine; Time Factors; Treatment Outcome | 2002 |
Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders.
Topics: Alkaloids; Alzheimer Disease; Estrogens, Non-Steroidal; Galantamine; Humans; Isoflavones; Physostigmine; Phytoestrogens; Phytotherapy; Plant Extracts; Plant Preparations; Plants, Medicinal; Sesquiterpenes | 2003 |
Dementia.
Topics: Alzheimer Disease; Anticonvulsants; Antipsychotic Agents; Carbamates; Donepezil; Galantamine; Ginkgo biloba; Humans; Indans; Nootropic Agents; Phenylcarbamates; Phosphatidylcholines; Physostigmine; Phytotherapy; Piperidines; Rivastigmine; Tacrine; Vitamin E | 2003 |
Dementia.
Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Cognition; Dementia; Donepezil; Galantamine; Ginkgo biloba; Haloperidol; Humans; Indans; Memantine; Olanzapine; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Risperidone; Rivastigmine; Selegiline; Tacrine; Vitamin E | 2004 |
Dementia.
Topics: Alzheimer Disease; Dementia; Donepezil; Galantamine; Ginkgo biloba; Humans; Indans; Memantine; Nootropic Agents; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Rivastigmine; Tacrine | 2004 |
Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Drug Delivery Systems; Drug Evaluation, Preclinical; Galantamine; Humans; Physostigmine; Protein Conformation | 2006 |
Dementia.
Topics: Alzheimer Disease; Benzodiazepines; Dementia; Donepezil; Galantamine; Ginkgo biloba; Humans; Indans; Memantine; Nootropic Agents; Olanzapine; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Rivastigmine; Selegiline; Tacrine | 2005 |
[Therapy of cognitive deficits in schizophrenia with acetylcholinesterase inhibitors. A systematic overview].
Topics: Antipsychotic Agents; Cholinesterase Inhibitors; Cognition Disorders; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Physostigmine; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2008 |
Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment.
Topics: Alkaloids; Alzheimer Disease; Binding Sites; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Indole Alkaloids; Isoquinolines; Phenylcarbamates; Physostigmine; Piperidines; Propidium; Rivastigmine; Steroids; Tacrine | 2007 |
Multitarget drugs of plants origin acting on Alzheimer's disease.
Topics: Alkaloids; Alzheimer Disease; Animals; Biological Products; Cholinesterase Inhibitors; Crocus; Drug Discovery; Galantamine; Galanthus; Ginkgo biloba; Humans; Huperzia; Neuroprotective Agents; Physostigmine; Plant Extracts; Plants; Salvia; Sesquiterpenes | 2013 |
1 trial(s) available for galantamine and physostigmine
Article | Year |
---|---|
Cholinergic neurotransmission, REM sleep and depression.
Topics: Adolescent; Adult; Aged; Alzheimer Disease; Brain Stem; Cholinergic Agonists; Cholinergic Fibers; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Galantamine; Humans; Male; Mental Disorders; Middle Aged; Parasympathomimetics; Physostigmine; Polysomnography; Reaction Time; Receptors, Muscarinic; Sleep Stages; Sleep Wake Disorders; Sleep, REM; Succinimides; Synaptic Transmission; Tacrine | 1994 |
51 other study(ies) available for galantamine and physostigmine
Article | Year |
---|---|
Flexible 1-[(2-aminoethoxy)alkyl]-3-ar(o)yl(thio)ureas as novel acetylcholinesterase inhibitors. Synthesis and biochemical evaluation.
Topics: Animals; Cholinesterase Inhibitors; Drug Evaluation, Preclinical; Molecular Conformation; Rats; Structure-Activity Relationship; Thiourea | 1995 |
Novel [2-(4-piperidinyl)ethyl](thio)ureas: synthesis and antiacetylcholinesterase activity.
Topics: Acetylcholinesterase; Amnesia; Animals; Avoidance Learning; Cholinesterase Inhibitors; Dementia; Dose-Response Relationship, Drug; Hydrogen Bonding; Mice; Molecular Conformation; Molecular Structure; Piperidines; Rats; Scopolamine; Structure-Activity Relationship; Thiourea | 1994 |
Anticholinesterase activity of compounds related to geneserine tautomers. N-Oxides and 1,2-oxazines.
Topics: Acetylcholinesterase; Alkaloids; Butyrylcholinesterase; Cholinesterase Inhibitors; Cyclic N-Oxides; Humans; Isomerism; Oxazines; Structure-Activity Relationship | 2002 |
Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine.
Topics: Acetylcholinesterase; Amyloid beta-Protein Precursor; Benzofurans; Butyrylcholinesterase; Carbamates; Cell Line; Cell Survival; Cholinesterase Inhibitors; Crystallography, X-Ray; Humans; Models, Molecular; Molecular Structure; Neurons; Oxepins; Structure-Activity Relationship | 2005 |
Inhibition of human acetyl- and butyrylcholinesterase by novel carbamates of (-)- and (+)-tetrahydrofurobenzofuran and methanobenzodioxepine.
Topics: Acetophenones; Acetylcholinesterase; Animals; Benzofurans; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Crystallography, X-Ray; Furans; Heterocyclic Compounds, 3-Ring; Humans; Models, Molecular; Oxepins; Stereoisomerism; Structure-Activity Relationship; Torpedo | 2006 |
6-Hydroxy- and 6-methoxy-beta-carbolines as acetyl- and butyrylcholinesterase inhibitors.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Carbolines; Cholinesterase Inhibitors; Galantamine; Humans; Inhibitory Concentration 50; Phenylcarbamates; Physostigmine; Rivastigmine; Serotonin | 2006 |
Acetylcholinesterase inhibitors from the toadstool Cortinarius infractus.
Topics: Acetylcholinesterase; Agaricales; Animals; Cattle; Cholinesterase Inhibitors; Erythrocytes; Fruiting Bodies, Fungal; Heterocyclic Compounds, 4 or More Rings; Molecular Structure; Stereoisomerism; Structure-Activity Relationship | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Dual inhibition of the α-glucosidase and butyrylcholinesterase studied by molecular field topology analysis.
Topics: alpha-Glucosidases; Butyrylcholinesterase; Cholinesterase Inhibitors; Drug Design; Glycoside Hydrolase Inhibitors; Inhibitory Concentration 50; Quantitative Structure-Activity Relationship | 2014 |
Cholinesterase inhibitory activity of isoquinoline alkaloids from three Cryptocarya species (Lauraceae).
Topics: Acetylcholinesterase; Alkaloids; Butyrylcholinesterase; Cholinesterase Inhibitors; Cryptocarya; Humans; Inhibitory Concentration 50; Isoquinolines; Kinetics; Molecular Docking Simulation; Plant Extracts; Spectrum Analysis | 2016 |
In silico studies, synthesis and pharmacological evaluation to explore multi-targeted approach for imidazole analogues as potential cholinesterase inhibitors with neuroprotective role for Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Electrophorus; Female; Horses; Imidazoles; Male; Maze Learning; Memory Disorders; Mice; Molecular Structure; Neuroprotective Agents; Structure-Activity Relationship | 2018 |
Aromatic Esters of the Crinane Amaryllidaceae Alkaloid Ambelline as Selective Inhibitors of Butyrylcholinesterase.
Topics: Amaryllidaceae; Amaryllidaceae Alkaloids; Blood-Brain Barrier; Butyrylcholinesterase; Cholinesterase Inhibitors; Esters; Humans; Models, Molecular; Molecular Docking Simulation; Molecular Structure; Substrate Specificity | 2020 |
Derivatives of montanine-type alkaloids and their implication for the treatment of Alzheimer's disease: Synthesis, biological activity and in silico study.
Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Blood-Brain Barrier; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Isoquinolines; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship | 2021 |
Pyrazolines as potential anti-Alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies.
Topics: | 2022 |
[Mechanism of the effect of diazepam on acetylcholine concentration in mouse brain].
Topics: Acetylcholine; Acetylcholinesterase; Animals; Brain; Brain Chemistry; Cholinesterase Inhibitors; Diazepam; Dose-Response Relationship, Drug; Galantamine; Lethal Dose 50; Male; Mice; Nitrobenzenes; Organophosphorus Compounds; Paraoxon; Physostigmine | 1978 |
[Galanthamine hydrobromide : a substitute for eserine sulphate (physostigmine) in the treatment of the cerebral effects of anti-cholinergic substances].
Topics: Animals; Brain Diseases; Galantamine; Humans; Parasympatholytics; Physostigmine | 1978 |
Inhibition of acetylcholinesterase activity in human brain tissue and erythrocytes by galanthamine, physostigmine and tacrine.
Topics: Acetylcholinesterase; Aged; Aged, 80 and over; Animals; Cerebral Cortex; Cholinesterase Inhibitors; Erythrocytes; Female; Galantamine; Hippocampus; Humans; Male; Mice; Middle Aged; Physostigmine; Tacrine | 1991 |
[The antimyorelaxant effect of cholinopotentiating drugs].
Topics: Ambenonium Chloride; Animals; Anura; Cholinesterase Inhibitors; Colorimetry; Galantamine; Male; Miotics; Neostigmine; Neuromuscular Nondepolarizing Agents; Organophosphonates; Phosphates; Physostigmine; Rats; Tubocurarine | 1970 |
[Influence of atropine and cholinesterase inhibitors on brain potentials caused by dental pulp stimulation].
Topics: Animals; Atropine; Brain; Cholinesterase Inhibitors; Dental Pulp; Electric Stimulation; Evoked Potentials; Female; Galantamine; Isoflurophate; Male; Paraoxon; Physostigmine; Rabbits | 1972 |
[Dose-action relationship in cholinergically induced theta rhythm in the rat hippocampus].
Topics: Animals; Bromides; Electrodes, Implanted; Electroencephalography; Evoked Potentials; Galantamine; Hippocampus; Nicotinic Acids; Parasympathomimetics; Physostigmine; Rats; Rats, Inbred Strains; Salicylates; Tremorine | 1971 |
[Effect of phenelzine on the toxicity of cholinergic drugs modified by reserpine].
Topics: Animals; Cholinesterase Inhibitors; Drug Interactions; Female; Galantamine; Isoflurophate; Lethal Dose 50; Male; Mice; Monoamine Oxidase Inhibitors; Neostigmine; Paraoxon; Parasympathomimetics; Phenelzine; Physostigmine; Reserpine; Toxicology | 1971 |
[Reactivity of isolated rat intestine to choline potentiating compounds].
Topics: Acetylcholine; Ambenonium Chloride; Animals; Cholinesterase Inhibitors; Depression, Chemical; Galantamine; Ileum; In Vitro Techniques; Male; Miotics; Muscle Contraction; Muscle, Smooth; Neostigmine; Nicotine; Nicotinic Acids; Organophosphonates; Parasympathomimetics; Phosphates; Physostigmine; Rats; Stimulation, Chemical | 1971 |
[Alteration of the primary response of the somatosensory area of the cortex on exposure to choline potentiating substances].
Topics: Animals; Cats; Cerebral Cortex; Cholinesterase Inhibitors; Electrophysiology; Epinephrine; Evoked Potentials; Galantamine; Neostigmine; Neurons; Parasympathetic Nervous System; Parasympatholytics; Physostigmine; Radial Nerve | 1967 |
Note on the ganglionic and central actions of galantamine.
Topics: Acetylcholine; Animals; Atropine; Benactyzine; Cats; Cerebral Cortex; Electroencephalography; Evoked Potentials; Galantamine; Ganglia, Autonomic; Hexamethonium Compounds; Hippocampus; Phenobarbital; Physostigmine; Stimulation, Chemical; Tubocurarine | 1968 |
Some structural requirements underlying holothurin A interactions with synaptic chemoreceptors.
Topics: Animals; Chemical Phenomena; Chemistry, Physical; Diaphragm; Galantamine; In Vitro Techniques; Neostigmine; Neurochemistry; Neuromuscular Junction; Phrenic Nerve; Physostigmine; Rats; Sensory Receptor Cells; Toxins, Biological | 1965 |
[Acetylcholinesterase and the bioelectrical activity of the brain under the action of eserine and galanthamine in animals with premesencephalic section of the brain].
Topics: Acetylcholinesterase; Animals; Brain; Cats; Electroencephalography; Galantamine; Mesencephalon; Physostigmine; Reticular Formation | 1965 |
Galanthamine chemistry. VII. Synthesis of analogues of galanthamine.
Topics: Animals; Chemistry, Organic; Cholinesterase Inhibitors; Galantamine; Neostigmine; Organic Chemistry Phenomena; Physostigmine | 1966 |
Study of the analgesic effects of galanthamine, a cholinesterase inhibitor.
Topics: Analgesics; Anesthesia; Animals; Barbiturates; Cats; Drug Synergism; Female; Galantamine; Guinea Pigs; In Vitro Techniques; Male; Mice; Morphine; Muscle Contraction; Muscle, Smooth; Physostigmine; Rats; Reaction Time | 1983 |
The involvement of the central cholinergic and endorphinergic systems in the nitrous oxide withdrawal syndrome in mice.
Topics: Animals; Brain; Endorphins; Galantamine; Humans; Male; Mice; Naloxone; Nitrous Oxide; Parasympathetic Nervous System; Physostigmine; Seizures; Substance Withdrawal Syndrome | 1983 |
[Effect of cholinesterase inhibitors on the electrical excitability of the membrane of frog muscle fiber].
Topics: Action Potentials; Animals; Anura; Armin; Cholinesterase Inhibitors; Drug Interactions; Electric Stimulation; Galantamine; In Vitro Techniques; Neuromuscular Junction; Physostigmine; Synaptic Membranes | 1982 |
Physostigmine, galanthamine and codeine act as 'noncompetitive nicotinic receptor agonists' on clonal rat pheochromocytoma cells.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Cholinesterase Inhibitors; Codeine; Galantamine; In Situ Hybridization; Ion Channels; Ligands; Nicotinic Agonists; Nicotinic Antagonists; Patch-Clamp Techniques; PC12 Cells; Physostigmine; Rats; Rats, Wistar; Receptors, Nicotinic; Structure-Activity Relationship | 1995 |
Effect of cholinesterase inhibition in vitro by huperzine analogs.
Topics: Acetylcholinesterase; Alkaloids; Animals; Cholinesterase Inhibitors; Erythrocyte Membrane; Galantamine; Physostigmine; Rats; Sesquiterpenes; Structure-Activity Relationship | 1994 |
Physostigmine and galanthamine: probes for a novel binding site on the alpha 4 beta 2 subtype of neuronal nicotinic acetylcholine receptors stably expressed in fibroblast cells.
Topics: Animals; Antibodies, Monoclonal; Bacterial Toxins; Binding Sites; Cells, Cultured; Chickens; Cyanobacteria Toxins; Dexamethasone; Dose-Response Relationship, Drug; Fibroblasts; Galantamine; Kinetics; Marine Toxins; Membrane Potentials; Microcystins; Molecular Probes; Neurons; Nicotine; Physostigmine; Receptors, Nicotinic; Recombinant Proteins; Tropanes | 1994 |
Identification and functional characterization of a new agonist site on nicotinic acetylcholine receptors of cultured hippocampal neurons.
Topics: Amino Acid Sequence; Animals; Antibodies; Binding Sites; Cells, Cultured; Evoked Potentials; Female; Fibroblasts; Galantamine; Hippocampus; Immunohistochemistry; Kinetics; Membranes; Molecular Sequence Data; Neurons; Physostigmine; Pregnancy; Quaternary Ammonium Compounds; Rats; Receptors, Nicotinic | 1993 |
Alpha 2-adrenoceptor antagonists potentiate acetylcholinesterase inhibitor effects on passive avoidance learning in the rat.
Topics: Adrenergic alpha-Antagonists; Animals; Avoidance Learning; Benzazepines; Cholinesterase Inhibitors; Drug Synergism; Galantamine; Idazoxan; Male; Physostigmine; Rats; Rats, Sprague-Dawley; Tacrine; Yohimbine | 1996 |
[Neuroprotective therapy of Alzheimer's disease?].
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Galantamine; Humans; Neuroprotective Agents; Physostigmine; Piracetam; Tacrine | 1996 |
Extended lifetime of reagentless detector for multiple inhibitors of acetylcholinesterase.
Topics: Acetylcholinesterase; Binding, Competitive; Biosensing Techniques; Cholinesterase Inhibitors; Diazinon; Enzymes, Immobilized; Equipment Design; Equipment Failure Analysis; Equipment Reuse; Galantamine; Indicators and Reagents; Octoxynol; Physostigmine; Porphyrins; Quality Control; Reproducibility of Results; Scopolamine; Sensitivity and Specificity; Spectrum Analysis; Tetracaine | 2003 |
[PARAMYON-INDUCED CONTRACTURE OF THE DORSAL MUSCLE OF A LEECH UNDER THE EFFECT OF ANTICHOLINESTERASE AGENTS].
Topics: Acetylcholine; Animals; Cholinesterase Inhibitors; Contracture; Galantamine; Leeches; Leeching; Muscle Relaxants, Central; Neostigmine; Pharmacology; Physostigmine; Research | 1963 |
Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Cholinesterase Inhibitors; Donepezil; Drug Synergism; Electric Stimulation; Galantamine; In Vitro Techniques; Indans; Male; Muscle Contraction; Muscle, Smooth; Nicotine; Nicotinic Agonists; Phenylcarbamates; Physostigmine; Piperidines; Rats; Rats, Wistar; Receptors, Purinergic; Rivastigmine; Stimulation, Chemical; Synaptic Transmission; Tacrine; Vas Deferens | 2004 |
Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanism.
Topics: Acetylcholine; Alkaloids; Animals; Atropine; Azocines; Binding, Competitive; Cholinergic Agents; Cholinesterase Inhibitors; Dichlorvos; Dose-Response Relationship, Drug; Female; Galantamine; Humans; Membrane Potentials; Models, Biological; Nicotine; Oocytes; Phenylcarbamates; Physostigmine; Plasmids; Quinolizines; Receptors, Nicotinic; Rivastigmine; Scopolamine; Tacrine; Xenopus laevis | 2005 |
Acute effects of physostigmine and galantamine on the binding of [18F]fluoro-A-85380: a PET study in monkeys.
Topics: Analysis of Variance; Animals; Azetidines; Binding, Competitive; Brain; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Fluorine Radioisotopes; Galantamine; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Papio papio; Physostigmine; Positron-Emission Tomography; Reproducibility of Results; Time Factors; Tissue Distribution | 2005 |
Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice.
Topics: Animals; Behavior, Animal; Cholinesterase Inhibitors; Cognition; Dizocilpine Maleate; Donepezil; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Galantamine; Indans; Learning; Male; Maze Learning; Mice; Mice, Inbred C57BL; Physostigmine; Piperidines; Receptors, Nicotinic | 2005 |
Effect of acetylcholinesterase inhibitors on the binding of nicotinic alpha4beta2 receptor PET radiotracer, (18)F-nifene: A measure of acetylcholine competition.
Topics: Acetylcholine; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cholinesterase Inhibitors; Fluorine Radioisotopes; Galantamine; Male; Physostigmine; Positron-Emission Tomography; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic | 2007 |
Inhibitory potency of choline esterase inhibitors on acetylcholine release and choline esterase activity in fresh specimens of human and rat neocortex.
Topics: Acetylcholine; Adolescent; Adult; Aged; Animals; Child; Child, Preschool; Cholinesterase Inhibitors; Cholinesterases; Donepezil; Galantamine; Humans; In Vitro Techniques; Indans; Middle Aged; Neocortex; Phenylcarbamates; Physostigmine; Piperidines; Rats; Rats, Wistar; Rivastigmine; Tacrine; Young Adult | 2009 |
Acetylcholinesterase inhibitors enhance cognitive functions in rats following hypobaric hypoxia.
Topics: Acetylcholine; Acetylcholinesterase; Air Pressure; Animals; Cerebral Cortex; Cholinesterase Inhibitors; Cognition; Cognition Disorders; Galantamine; Hippocampus; Hypoxia; Male; Maze Learning; Memory; Neurons; Neuroprotective Agents; Physostigmine; Random Allocation; Rats; Rats, Sprague-Dawley | 2009 |
Cholinesterase inhibitors ameliorate spatial learning deficits in rats following hypobaric hypoxia.
Topics: Acetylcholine; Acetylcholinesterase; Animals; CA1 Region, Hippocampal; CA3 Region, Hippocampal; Cerebral Cortex; Cholinesterase Inhibitors; Galantamine; Hypoxia; Learning Disabilities; Maze Learning; Nootropic Agents; Physostigmine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Space Perception | 2010 |
Acetylcholinesterase inhibitors partially generalize to nicotine discriminative stimulus effect in rats.
Topics: Animals; Cholinesterase Inhibitors; Conditioning, Operant; Discrimination Learning; Dose-Response Relationship, Drug; Galantamine; Generalization, Stimulus; Male; Nicotine; Nicotinic Agonists; Physostigmine; Rats; Rats, Sprague-Dawley; Tacrine | 2011 |
Possible role of cholinesterase inhibitors on memory consolidation following hypobaric hypoxia of rats.
Topics: Acetylcholine; Air Pressure; Altitude Sickness; Animals; Cholinesterase Inhibitors; Disease Models, Animal; Galantamine; Hypoxia, Brain; Male; Maze Learning; Memory; Memory Disorders; Physostigmine; Rats; Rats, Sprague-Dawley; Time Factors; Treatment Outcome | 2011 |
Physostigmine and galanthamine bind in the presence of agonist at the canonical and noncanonical subunit interfaces of a nicotinic acetylcholine receptor.
Topics: Algorithms; Animals; Binding Sites; Cholinergic Agonists; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Galantamine; Hydrolysis; In Vitro Techniques; Ion Channels; Models, Molecular; Peptide Hydrolases; Photochemistry; Physostigmine; Polymerase Chain Reaction; Radioligand Assay; Receptors, GABA-A; Receptors, Nicotinic; Torpedo | 2013 |
PET imaging of acetylcholinesterase inhibitor-induced effects on α4β2 nicotinic acetylcholine receptor binding.
Topics: Animals; Brain; Cholinesterase Inhibitors; Female; Galantamine; Physostigmine; Positron-Emission Tomography; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic | 2013 |
Multiple cholinesterase inhibitors have antidepressant-like properties in the mouse forced swim test.
Topics: Animals; Antidepressive Agents; Association Learning; Behavior, Animal; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Drug Repositioning; Galantamine; Male; Mice; Mice, Inbred C57BL; Motor Activity; Physostigmine; Rivastigmine; Swimming | 2021 |